Global Recombinant Human Basic Fibroblast Growth Factor Market Growth (Status and Outlook) 2026-2032

June 2026 | 75 pages | ID: G118845F7AD1EN
LP Information

Abstracts

The global Recombinant Human Basic Fibroblast Growth Factor market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Recombinant human basic fibroblast growth factor (rh-bFGF) is a protein produced through genetic engineering technology, which has the ability to promote cell repair and regeneration.

United States market for Recombinant Human Basic Fibroblast Growth Factor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Recombinant Human Basic Fibroblast Growth Factor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Recombinant Human Basic Fibroblast Growth Factor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Recombinant Human Basic Fibroblast Growth Factor players cover Merck, PeproTech, Cellregen, Abbkine, EssexBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Recombinant Human Basic Fibroblast Growth Factor Industry Forecast? looks at past sales and reviews total world Recombinant Human Basic Fibroblast Growth Factor sales in 2025, providing a comprehensive analysis by region and market sector of projected Recombinant Human Basic Fibroblast Growth Factor sales for 2026 through 2032. With Recombinant Human Basic Fibroblast Growth Factor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Basic Fibroblast Growth Factor industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Human Basic Fibroblast Growth Factor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Human Basic Fibroblast Growth Factor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Recombinant Human Basic Fibroblast Growth Factor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Basic Fibroblast Growth Factor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Basic Fibroblast Growth Factor.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Basic Fibroblast Growth Factor market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Purity >95%
• Purity >96%

Segmentation by Application:

• Medical
• Scientific Research
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• PeproTech
• Cellregen
• Abbkine
• EssexBio

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Human Basic Fibroblast Growth Factor Market Size (2021-2032)
  2.1.2 Recombinant Human Basic Fibroblast Growth Factor Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Recombinant Human Basic Fibroblast Growth Factor by Country/Region (2021, 2025 & 2032)
2.2 Recombinant Human Basic Fibroblast Growth Factor Segment by Type
  2.2.1 Purity >95%
  2.2.2 Purity >96%
  2.2.3 Recombinant Human Basic Fibroblast Growth Factor Market Size by Type
    2.2.3.1 Recombinant Human Basic Fibroblast Growth Factor Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Type (2021-2026)
2.3 Recombinant Human Basic Fibroblast Growth Factor Segment by Application
  2.3.1 Medical
  2.3.2 Scientific Research
  2.3.3 Others
  2.3.4 Recombinant Human Basic Fibroblast Growth Factor Market Size by Application
    2.3.4.1 Recombinant Human Basic Fibroblast Growth Factor Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Application (2021-2026)

3 RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH FACTOR MARKET SIZE BY PLAYER

3.1 Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Player
  3.1.1 Global Recombinant Human Basic Fibroblast Growth Factor Revenue by Player (2021-2026)
  3.1.2 Global Recombinant Human Basic Fibroblast Growth Factor Revenue Market Share by Player (2021-2026)
3.2 Global Recombinant Human Basic Fibroblast Growth Factor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH FACTOR BY REGION

4.1 Recombinant Human Basic Fibroblast Growth Factor Market Size by Region (2021-2026)
4.2 Global Recombinant Human Basic Fibroblast Growth Factor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Recombinant Human Basic Fibroblast Growth Factor Market Size Growth (2021-2026)
4.4 APAC Recombinant Human Basic Fibroblast Growth Factor Market Size Growth (2021-2026)
4.5 Europe Recombinant Human Basic Fibroblast Growth Factor Market Size Growth (2021-2026)
4.6 Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Recombinant Human Basic Fibroblast Growth Factor Market Size by Country (2021-2026)
5.2 Americas Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026)
5.3 Americas Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Recombinant Human Basic Fibroblast Growth Factor Market Size by Region (2021-2026)
6.2 APAC Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026)
6.3 APAC Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Recombinant Human Basic Fibroblast Growth Factor Market Size by Country (2021-2026)
7.2 Europe Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026)
7.3 Europe Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor by Region (2021-2026)
8.2 Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026)
8.3 Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH FACTOR MARKET FORECAST

10.1 Global Recombinant Human Basic Fibroblast Growth Factor Forecast by Region (2027-2032)
  10.1.1 Global Recombinant Human Basic Fibroblast Growth Factor Forecast by Region (2027-2032)
  10.1.2 Americas Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.1.3 APAC Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.1.4 Europe Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.1.5 Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Forecast
10.2 Americas Recombinant Human Basic Fibroblast Growth Factor Forecast by Country (2027-2032)
  10.2.1 United States Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.2.2 Canada Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.2.3 Mexico Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.2.4 Brazil Market Recombinant Human Basic Fibroblast Growth Factor Forecast
10.3 APAC Recombinant Human Basic Fibroblast Growth Factor Forecast by Region (2027-2032)
  10.3.1 China Recombinant Human Basic Fibroblast Growth Factor Market Forecast
  10.3.2 Japan Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.3.3 Korea Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.3.4 Southeast Asia Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.3.5 India Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.3.6 Australia Market Recombinant Human Basic Fibroblast Growth Factor Forecast
10.4 Europe Recombinant Human Basic Fibroblast Growth Factor Forecast by Country (2027-2032)
  10.4.1 Germany Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.4.2 France Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.4.3 UK Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.4.4 Italy Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.4.5 Russia Market Recombinant Human Basic Fibroblast Growth Factor Forecast
10.5 Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Forecast by Region (2027-2032)
  10.5.1 Egypt Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.5.2 South Africa Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.5.3 Israel Market Recombinant Human Basic Fibroblast Growth Factor Forecast
  10.5.4 Turkey Market Recombinant Human Basic Fibroblast Growth Factor Forecast
10.6 Global Recombinant Human Basic Fibroblast Growth Factor Forecast by Type (2027-2032)
10.7 Global Recombinant Human Basic Fibroblast Growth Factor Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Recombinant Human Basic Fibroblast Growth Factor Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck Recombinant Human Basic Fibroblast Growth Factor Product Offered
  11.1.3 Merck Recombinant Human Basic Fibroblast Growth Factor Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 PeproTech
  11.2.1 PeproTech Company Information
  11.2.2 PeproTech Recombinant Human Basic Fibroblast Growth Factor Product Offered
  11.2.3 PeproTech Recombinant Human Basic Fibroblast Growth Factor Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 PeproTech Main Business Overview
  11.2.5 PeproTech Latest Developments
11.3 Cellregen
  11.3.1 Cellregen Company Information
  11.3.2 Cellregen Recombinant Human Basic Fibroblast Growth Factor Product Offered
  11.3.3 Cellregen Recombinant Human Basic Fibroblast Growth Factor Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Cellregen Main Business Overview
  11.3.5 Cellregen Latest Developments
11.4 Abbkine
  11.4.1 Abbkine Company Information
  11.4.2 Abbkine Recombinant Human Basic Fibroblast Growth Factor Product Offered
  11.4.3 Abbkine Recombinant Human Basic Fibroblast Growth Factor Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Abbkine Main Business Overview
  11.4.5 Abbkine Latest Developments
11.5 EssexBio
  11.5.1 EssexBio Company Information
  11.5.2 EssexBio Recombinant Human Basic Fibroblast Growth Factor Product Offered
  11.5.3 EssexBio Recombinant Human Basic Fibroblast Growth Factor Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 EssexBio Main Business Overview
  11.5.5 EssexBio Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Recombinant Human Basic Fibroblast Growth Factor Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Recombinant Human Basic Fibroblast Growth Factor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Purity >95%
Table 4. Major Players of Purity >96%
Table 5. Recombinant Human Basic Fibroblast Growth Factor Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Type (2021-2026)
Table 8. Recombinant Human Basic Fibroblast Growth Factor Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Application (2021-2026)
Table 11. Global Recombinant Human Basic Fibroblast Growth Factor Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Recombinant Human Basic Fibroblast Growth Factor Revenue Market Share by Player (2021-2026)
Table 13. Recombinant Human Basic Fibroblast Growth Factor Key Players Head office and Products Offered
Table 14. Recombinant Human Basic Fibroblast Growth Factor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Recombinant Human Basic Fibroblast Growth Factor Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Region (2021-2026)
Table 19. Global Recombinant Human Basic Fibroblast Growth Factor Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Recombinant Human Basic Fibroblast Growth Factor Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Recombinant Human Basic Fibroblast Growth Factor Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Country (2021-2026)
Table 23. Americas Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Type (2021-2026)
Table 25. Americas Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Application (2021-2026)
Table 27. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Region (2021-2026)
Table 29. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Country (2021-2026)
Table 33. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Recombinant Human Basic Fibroblast Growth Factor
Table 39. Key Market Challenges & Risks of Recombinant Human Basic Fibroblast Growth Factor
Table 40. Key Industry Trends of Recombinant Human Basic Fibroblast Growth Factor
Table 41. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Merck Details, Company Type, Recombinant Human Basic Fibroblast Growth Factor Area Served and Its Competitors
Table 46. Merck Recombinant Human Basic Fibroblast Growth Factor Product Offered
Table 47. Merck Recombinant Human Basic Fibroblast Growth Factor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Merck Main Business
Table 49. Merck Latest Developments
Table 50. PeproTech Details, Company Type, Recombinant Human Basic Fibroblast Growth Factor Area Served and Its Competitors
Table 51. PeproTech Recombinant Human Basic Fibroblast Growth Factor Product Offered
Table 52. PeproTech Recombinant Human Basic Fibroblast Growth Factor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. PeproTech Main Business
Table 54. PeproTech Latest Developments
Table 55. Cellregen Details, Company Type, Recombinant Human Basic Fibroblast Growth Factor Area Served and Its Competitors
Table 56. Cellregen Recombinant Human Basic Fibroblast Growth Factor Product Offered
Table 57. Cellregen Recombinant Human Basic Fibroblast Growth Factor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Cellregen Main Business
Table 59. Cellregen Latest Developments
Table 60. Abbkine Details, Company Type, Recombinant Human Basic Fibroblast Growth Factor Area Served and Its Competitors
Table 61. Abbkine Recombinant Human Basic Fibroblast Growth Factor Product Offered
Table 62. Abbkine Recombinant Human Basic Fibroblast Growth Factor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Abbkine Main Business
Table 64. Abbkine Latest Developments
Table 65. EssexBio Details, Company Type, Recombinant Human Basic Fibroblast Growth Factor Area Served and Its Competitors
Table 66. EssexBio Recombinant Human Basic Fibroblast Growth Factor Product Offered
Table 67. EssexBio Recombinant Human Basic Fibroblast Growth Factor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. EssexBio Main Business
Table 69. EssexBio Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Human Basic Fibroblast Growth Factor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Recombinant Human Basic Fibroblast Growth Factor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Recombinant Human Basic Fibroblast Growth Factor Sales Market Share by Country/Region (2025)
Figure 8. Recombinant Human Basic Fibroblast Growth Factor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Type in 2025
Figure 10. Recombinant Human Basic Fibroblast Growth Factor in Medical
Figure 11. Global Recombinant Human Basic Fibroblast Growth Factor Market: Medical (2021-2026) & ($ millions)
Figure 12. Recombinant Human Basic Fibroblast Growth Factor in Scientific Research
Figure 13. Global Recombinant Human Basic Fibroblast Growth Factor Market: Scientific Research (2021-2026) & ($ millions)
Figure 14. Recombinant Human Basic Fibroblast Growth Factor in Others
Figure 15. Global Recombinant Human Basic Fibroblast Growth Factor Market: Others (2021-2026) & ($ millions)
Figure 16. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Application in 2025
Figure 17. Global Recombinant Human Basic Fibroblast Growth Factor Revenue Market Share by Player in 2025
Figure 18. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Region (2021-2026)
Figure 19. Americas Recombinant Human Basic Fibroblast Growth Factor Market Size 2021-2026 ($ millions)
Figure 20. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size 2021-2026 ($ millions)
Figure 21. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size 2021-2026 ($ millions)
Figure 23. Americas Recombinant Human Basic Fibroblast Growth Factor Value Market Share by Country in 2025
Figure 24. United States Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Region in 2025
Figure 29. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Type (2021-2026)
Figure 30. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Application (2021-2026)
Figure 31. China Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 35. India Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Country in 2025
Figure 38. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Type (2021-2026)
Figure 39. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Application (2021-2026)
Figure 40. Germany Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 41. France Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Recombinant Human Basic Fibroblast Growth Factor Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 54. APAC Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 55. Europe Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 57. United States Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 58. Canada Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 59. Mexico Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 60. Brazil Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 61. China Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 62. Japan Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 63. Korea Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 65. India Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 66. Australia Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 67. Germany Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 68. France Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 69. UK Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 70. Italy Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 71. Russia Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 72. Egypt Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 73. South Africa Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 74. Israel Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 75. Turkey Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)
Figure 76. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Recombinant Human Basic Fibroblast Growth Factor Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Recombinant Human Basic Fibroblast Growth Factor Market Size 2027-2032 ($ millions)